mRNA-1273.351
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for mRNA-1273.351, covering 2023-09-13 to 2023-09-13. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated Adults [Phase 1]